The amount of fluid in patients receiving routine hemodialysis treatment is measured by using body composition monitor.
Not Applicable
- Conditions
- Health Condition 1: N186- End stage renal disease
- Registration Number
- CTRI/2023/11/060127
- Lead Sponsor
- Vinay Harihar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age greater than 18 years.
At least on twice weekly hemodialysis more than 3 months.
Exclusion Criteria
Individual with pacemaker, Metallic joints/pins/clips and amputated major limb.
Patients on Peritoneal dialysis, patients with acute kidney injury.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the body fluid status in maintenance hemodialysis patients using a Body Composition Monitor.Timepoint: Outcome will be assessed at baseline soon after CTRI approval.
- Secondary Outcome Measures
Name Time Method To assess the mean pre-hemodialysis blood pressure level of patients in the overhydration group, normal hydration group, & underhydration group.Timepoint: Outcome will be assessed at baseline soon after CTRI approval.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biomarkers correlate with fluid overload in ESRD patients using body composition monitoring during hemodialysis?
How does body composition monitoring compare to bioimpedance in assessing fluid status for maintenance hemodialysis patients?
Which molecular pathways link fluid imbalance to cardiovascular outcomes in end-stage renal disease (N186) patients?
What adverse events are associated with fluid mismanagement in ESRD patients, and how does real-time monitoring mitigate risks?
How does body composition monitoring integrate with ultrafiltration rate adjustments in hemodialysis therapy optimization?